San Diego, CA · Founded 2024 · Privately Held (backing)
Developer of precision medicine technologies designed to address unmet needs in immune-mediated and inflammatory diseases. Mirador Therapeutics is based in San Diego, CA and was founded in 2024. It was valued at $1 billion at its early-stage round in Jan 2026, the last priced event on record. It has raised $735 million across 2 recorded rounds; the latest was a $333 million later-stage round in Feb 2024.
PMV mark · valuation
$1.0B
Oct 2026
Priced at
its early-stage round
Jan 2026
Total raised
$735.0M
Last round
Later Stage VC
Feb 2024
Cap table — not yet on record
Mirador Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mirador Therapeutics with a free account
·The complete investor list: 17 names
·Watch Mirador Therapeutics: the Monday email on marks, rounds and moves
Where does Mirador Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Mirador Therapeutics's 2 recorded funding rounds.
